This enduring material will provide health care professionals with the necessary tools to navigate FDA’s drug information resources efficiently and effectively. This enduring material will discuss questions received by FDA’s Division of Drug Information and how to answer them using FDA’s drug information resources. This enduring material will also provide an overview of the many ways health care professionals can stay connected to drug information news and updates from FDA’s Division of Drug Information.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 10903 New Hampshire Avenue (HFD-220)
Pricing
100% of listed courses are free
23 of 23 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- General & Adult Psychiatry
- General Pediatrics
- Hospital Medicine
- Infectious Disease
- Medical Leadership & Administration
- Medical Oncology
- Neurology
- Obstetrics & Gynecology
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Practice Management & Ethics
- Psychopharmacology
- Cross-Specialty
- Infectious Disease
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
-
ReleasedMay 21, 2024
-
Last day to claim creditMay 21, 2027 7 months left
-
Food & Drug Administration – Center for Drug Evaluation & Research FDA Rare Disease Day 2024: Navigating Information. Empowering Patients and Providers
-
Food & Drug Administration – Center for Drug Evaluation & Research FDA Drug Safety Podcast: FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use
-
Food & Drug Administration – Center for Drug Evaluation & Research FDA Drug Safety Podcast: FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions
